Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LAN1 |
Human neuroblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. Groß et al., Cancer Res., 2018, DOI: 10.1158/0008-5472.CAN-17-1860 | |||
L-02 |
Human fetal hepatocyte cell line | Human | digestive organs | cell line | siRNA | RNA-Interference | Metafectene | publication | R. Liu et al., Tumor Biology, April 2017: 1 -13, doi.org/10.1177/1010428317695031 | Link | |||
KGN |
Human ovary granulosa-like tumor cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | D. Fu et al., Endocr. Relat. Cancer, Mar 2014; 21: 297 - 310 | Link | ||
KGN |
Human ovary granulosa-like tumor cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C. Wang et al., Am. .J Transl. Res., 2012, 4 (4): 390-402 | Link | ||
KGN |
Human ovary granulosa-like tumor cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | T. Sugawara et al., J. Biol. Chem., Oct 2003; 278: 42487 - 42494 | Link | ||
KG1 |
Human myelogenous leukemia cell line | ATCC CRL-8031 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | B. Landry et al., PLoS ONE, 2012, 7(8): e44197, doi:10.1371/journal.pone.0044197 | Link | |
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | M. Merkerova et al., Mol Biol Rep, Mar 2007; 34(1): 27-33 | ||
Jurkat |
Human leukemia T-cell line | ECACC 88042803 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | R. Avellino et al., Blood, Aug 2005; 106: 1400 - 1406 | Link | |
INS-1E |
Rat pancreatic tumor (insulinoma) derived ß cell line | Rat | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Cadavez Trigo, PhD Thesis, 2014, Seoul National University | Link | ||
INS-1E |
Rat pancreatic tumor (insulinoma) derived ß cell line | Rat | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Cadavez et al., PLoS ONE, 2014, 9(7): e101797, doi:10.1371/journal.pone.0101797 | Link | ||
INS-1E |
Rat pancreatic tumor (insulinoma) derived ß cell line | Rat | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. A. Rebuffat et al., Diabetologia, 2013, 56: 2446–2455, DOI 10.1007/s00125-013-3030-x | Link | ||
IMR-90 |
Human primary lung fibroblasts | ATCC CCL-186 | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | A. M. Szekely et al., Mol. Cell. Biol., Dec 2005; 25: 10492 - 10506 | Link | |
IMR-90 |
Human primary lung fibroblasts | ATCC CCL-186 | Human | respiratory system | primary cell | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene | publication | A. M. Szekely et al., Mol. Cell. Biol., Dec 2005; 25: 10492 - 10506 | Link | |
IGR-37 |
Human cutaneous melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Venza et al., Int. Immunopharmacol., 2014, 21: 439–446; doi.org/10.1016/j.intimp.2014.05.024 | |||
hVSMC |
Human vascular (aortic) smooth muscle cells | Human | vasculature | unknown | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Giordano et al., Cardiovasc Res, Aug 2008; 79: 519 - 526 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Giordano et al., Am J Physiol Heart Circ Physiol, Jan 2012; 302: H135 - H142 | Link | |
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S.-W. Lee et al., Molecular Therapy, 2013, 21 (9): 1767–1777, doi:10.1038/mt.2013.146 | Link | |
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | J. Park et al., Biochem. and Biophys. Res. Commun., 2018, 495: 2050e2057 | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | H.-Y. Lee et al., Cardiovasc Res, Jan 2013; 97: 143 - 152 | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | J. Park et al., Biochem. and Biophys. Res. Commun., 2018, 495: 2050-2057, doi.org/10.1016/j.bbrc.2017.08.023 | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | H.-Y. Lee et al., Korean Circ. J., 2012, 42: 239-245, doi.org/10.4070/kcj.2012.42.4.239 | Link | |
HuH7 |
Human hepatocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Ullio et al., J. Lipid Res., Jun 2012; 53: 1134 - 1143 | Link | ||
hTSMC |
Human primary tracheal smooth muscle cells | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-W. Lee et al., Mol. Pharmacol., May 2008; 73: 1454 - 1464 | |||
hTSMC |
Human primary tracheal smooth muscle cells | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-K. Hsu et al., J. Cell. Physiol., 2015, 230: 702-715; DOI: 10.1002/jcp.24795 | |||
hTSMC |
Human primary tracheal smooth muscle cells | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-C. Lin et al., Am. J. Physiol. Lung Cell Mol. Physiol., 2015, 309: L211-L225; doi:10.1152/ajplung.00232.2014 | Link |